CHEMOMAB THERAPEUTICS LTD. - AMERICAN DEPOSITARY

1.9000

11-二月-25 13:36:18

15 分钟延时

股票

-0.0900

-4.52%

今日范围

1.9000 - 1.9799

ISIN

N/A

来源

NASDAQ

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

24 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis

18 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024

02 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis

25 3月 2024 07:06:46 条件 Nasdaq GlobeNewswire

<<
<
1
2
>

我同意 NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie 政策, 隐私政策 and 条款与条件.